Bharat Seats Limited has informed the stock exchanges that its Board of Directors will meet on Wednesday, May 6, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The meeting has been convened pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for Board Meeting

The board will deliberate on the following key items:

• To consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2026
• To consider and recommend dividend on Equity Shares, if any, for the Financial Year ended March 31, 2026

Trading Window Closure

The company has informed that the trading window for dealing in the securities of Bharat Seats Limited will remain closed until the expiry of 48 hours from the submission of the financial results to the stock exchanges. This closure is in accordance with the Company's Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders.

The intimation was signed by Ritu Bakshi, Company Secretary and Compliance Officer of Bharat Seats Limited, on April 30, 2026. The company is listed on BSE Limited with scrip code 523229 and on National Stock Exchange of India Limited with scrip code BHARATSE.

Bharat Seats Limited has announced a substantial acquisition disclosure regarding the acquisition of equity shares by Rohit Relan Family Trust during the financial year 2025-26. The company informed the stock exchange about this development on April 28, 2026, in compliance with regulatory requirements.

Acquisition Details

The disclosure reveals significant shareholding changes in the company's ownership structure:

Regulatory Compliance

The acquisition was conducted under specific regulatory provisions and exemptions. The trust operated under SEBI exemption order no. WTM/KCV/CFD/03/2025-26 dated September 4, 2025, issued under Regulation 11(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

As per the exemption order requirements, the trust obtained compliance certification from an independent auditor. The compliance certificate was issued on April 16, 2026, confirming adherence to the prescribed regulatory framework.

Disclosure Process

Bharat Seats Limited received the disclosure documents along with the compliance status certificate from Rohit Relan Family Trust. Company Secretary and Compliance Officer Ritu Bakshi (Membership No. F3401) signed the disclosure letter on behalf of the company.

The disclosure was made pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in substantial shareholding changes. The company has forwarded copies of the disclosure to both the stock exchanges and SEBI for their records and public dissemination.

Trust Information

Rohit Relan serves as the Managing Trustee of Rohit Relan Family Trust. The trust is based at 25, Sardar Patel Marg, Chanakyapuri, New Delhi - 110021. The acquisition represents a significant investment in Bharat Seats Limited, establishing the trust as a substantial shareholder in the automotive seating solutions company.